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Abstract
Background: Neural precursor cells (NPCs) are defined by their ability to proliferate, self-renew,
and retain the potential to differentiate into neurons and glia. Deciphering the factors that regulate
their behaviors will greatly aid in their use as potential therapeutic agents or targets. Chondroitin
sulfate proteoglycans (CSPGs) are prominent components of the extracellular matrix (ECM) in the
central nervous system (CNS) and are assumed to play important roles in controlling neuronal
differentiation and development.
Results: In the present study, we demonstrated that CSPGs were constitutively expressed on the
NPCs isolated from the E16 rat embryonic brain. When chondroitinase ABC was used to abolish
the function of endogenous CSPGs on NPCs, it induced a series of biological responses including
the proliferation, differentiation and migration of NPCs, indicating that CSPGs may play a critical
role in NPC development and differentiation. Finally, we provided evidence suggesting that integrin
signaling pathway may be involved in the effects of CSPGs on NPCs.
Conclusion: The present study investigating the influence and mechanisms of CSPGs on the
differentiation and migration of NPCs should help us to understand the basic biology of NPCs
during CNS development and provide new insights into developing new strategies for the
treatment of the neurological disorders in the CNS.
Background
Neural precursor cells (NPCs) are defined by their ability
to proliferate, self-renew, and retain the potential to dif-
ferentiate into neurons and glia. In recent years, NPCs
have garnered much attention because they can reveal
clues about the nervous system development [1] and pos-
sibly be used as promising therapeutic agents. NPC trans-
plantation has the potential to ameliorate various
neurological diseases and injuries, such as Parkinson's
disease, Huntington's disease, stroke, and traumatic brain
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injury, and lead to partial functional recovery [2,3]. It has
been reported that the endogenous NPCs in the brain
reside in a specialized compartment termed "niche"
which is a specialized microenvironment composed of
soluble factors, membrane-bound molecules and extracel-
lular matrix (ECM) constituents that may regulate NPC
function [4,5].
The ECM environment in the central nervous system
(CNS) is responsible for a large number of regulatory
functions both during development and adulthood. It
provides signals for cell growth, differentiation and migra-
tion. These activities are critical for the development of
CNS and disruptions of ECM interactions can cause severe
developmental defects [6]. Several groups have shown
that ECM affects rodent NPCs proliferation, migration,
and differentiation both in vitro [7,8] and vivo [9], and
signals from the well-defined surrounding matrix are
involved in the regulation of NPCs. Recently, there is
growing evidence that the functions of ECM on NPCs are
mediated through the activation of integrin and MAP
kinase pathways [10-12]. Integrins are a major group of
cell-surface receptors for both ECM and cell-surface mole-
cules. They are the primary mediator of neural cell behav-
ior on ECM components and control various nervous
system cell functions including survival [13], migration
[14,15], neurite outgrowth [16], and myelination [17].
However, the mechanism by which integrin regulates
NPC behavior remains largely unexplored.
Chondroitin sulfate proteoglycans (CSPGs) are promi-
nent components of the ECM in the CNS and are assumed
to play a particularly important role in controlling neuro-
nal differentiation and development. During develop-
ment, they appear to function in axon guidance by
restricting axon growth to inappropriate targets [18], as
well inhibit the migration of neural crest cells [19]. Later
in development and in adulthood, they have been shown
to regulate the neuronal plasticity by forming perineuro-
nal nets around synapses [20,21]. In damaged nervous
system, they exert growth-inhibitory activities in the glial
scar such as hampering axon regeneration or compensa-
tory sprouting [22-24]. Though it was reported that
CSPGs were expressed on NPCs in culture and could be
secreted into media [25], little is known about their phys-
iological role in the development of NPCs in the CNS.
It has been well known that the application of Chondroi-
tinase ABC (Chase ABC) can promote axonal regeneration
by digesting CSPGs after spinal cord injury [26-28], and
NPC transplantation is another promising strategy for spi-
nal cord injury therapy. Recently, researchers found that
the combination of the two strategies could significantly
induce the outgrowth of GAP-43+ fibers at the lesion epi-
center of injured spinal cord, compared with either ther-
apy alone [25]. However, an important detail has not
been addressed, i.e. were the proliferation and differenti-
ation of transplanted NPCs affected by their exposure to
Chase ABC?
In the present study, we used Chase ABC to eliminate the
effects of endogenous CSPGs and determined whether
such elimination resulted in abnormal growth properties
of NPCs. Furthermore, we also examined whether integrin
signal pathways were involved in mediating the biological
effects of CSPGs on NPCs.
Methods
Isolation and cultivation of NPCs
Neural precursor cells were prepared according to the
method of Hu [29], with appreciable modifications.
Briefly, NPCs were isolated from the embryonic brain of
the E16 Sprague-Dawley rat. After removal of the amnion
and dura, the brain was dissected out in a sterile dish con-
taining ice-cold Leibovitz's L15 medium (Invitrogen,
Grand Island, NY, USA), and dissociated by gentle
mechanical pipeting through fire-polished Pasteur
pipettes to achieve single-cell suspensions. The dissoci-
ated cells were filtered through a nylon mesh of 70 μm
(Falcon, NJ, USA), seeded into a T25 Corning tissue cul-
ture flask (Corning Inc., Corning, NY, USA) containing
growth medium at a density of 1 × 105cells/ml, and incu-
bated in a humid atmosphere containing 5% CO2  at
37°C. The culture medium for NPCs contained: 1 × Dul-
becco's Modified Eagle's Medium/F12 (DMEM/F12, Invit-
rogen), 1 × N2 (Invitrogen), 2% B27 (Invitrogen), 0.06%
glucose, and 2 mM glutamine (Invitrogen), 1.34 mM
bicarbonate sodium, 0.5 mM HEPES, 2 μg/ml heparin (all
from Sigma, St.Louis, MO, USA), and freshly added 20 ng/
ml epidermal growth factor (EGF, Sigma) and 20 ng/ml
bFGF (Invitrogen). After 3 or 4 days, the cells grew and
developed into visible neurospheres of 50-200 cells/
sphere; then they were collected and mechanically pipet-
ted into single cells for passage. The NPCs of passage 2
were collected for the following assay.
To identify the expression of CSPGs on the NPCs, 50 μl
dissociated cells in single-cell suspension were seeded
onto laminin (10 μg/ml, Gibco) coated coverslips in 35-
mm dishes at a density of 3 × 104 cells/coverslip, and cul-
tured in NPC growth medium supplemented with EGF
and bFGF. 48 hours after culture, the cells were fixed for
immunostaining.
All embryonic rats were obtained from female pregnant
SD rats bred in the Animal Care Facility at Shanghai Jiao-
tong University School of Medicine. All animal care was
performed in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 80-23; revised 1996).BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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Differentiation of NPCs
To induce the differentiation of NPCs, 65 μl dissociated
cells in single-cell suspension were seeded onto poly-L-
lysine (200 μg/ml, Sigma) coated coverslips in 35-mm
dishes at a density of 5 × 104 cells/coverslip. Then, growth
factors were removed from the growth medium, and 1%
fetal bovine serum (FBS, Invitrogen) was added. The cul-
tures were allowed to differentiate for 5 days in vitro
before being fixed for immunostaining.
[3H] Thymidine Incorporation Assay
NPCs of passage 2 were dissociated and transferred to 96-
well plates (1.0 × 104cells/100 μl/well), after that, another
100 μl of different concentrations (0.05-50 mU/mL) of
Chondroitinase ABC (Chase ABC, Seikagaku, Tokyo,
Japan) or 100 μl medium alone (control) were added to
the wells, then cultured in medium with EGF and bFGF
for 24 hours at 37°C containing 5% CO2. And 1 μCi/well
[3H] thymidine (Amersham Piscataway, NJ, USA) was
added to the cultures for the last 16 hours. The cells were
harvested on fiberglass filters (Whatman, Kent, UK) using
a cell harvester (Tomtec, CT, USA). Incorporated radioac-
tivity was measured using standard scintillation tech-
niques.
Immunocytochemistry (ICH)
For floating neurospheres, they were harvested and fixed
using 4% paraformaldehyde (PFA) in 0.01 M PBS (pH
7.4) at 4°C overnight and cryoprotected in PBS contain-
ing 30% sucrose, then embedded in OCT (Sakura FineTec
Inc., Torrance, CA, USA) and sectioned with a cryostat. For
cell cultures on the coverslips, they needed to be fixed
with 4% PFA for 10 min at room temperature (RT) in
advance, then washed and stored in 0.01 M PBS (PH7.4).
Thereafter, the sections of neurospheres or cell cultures
were blocked in 10% goat serum in PBS (for cell surface
staining) or 0.3% Triton X-100-containing 10% goat
serum in PBS (for intracellular staining) for 1 hour at RT,
then sequentially incubated with the following primary
antibodies overnight at 4°C: the monoclonal mouse anti-
bodies IgM against CS-56 (1:200, Sigma) for CSPGs, the
monoclonal mouse antibodies IgG against nestin (1:800,
BD Pharmingen, San Jose, CA, USA) for NPCs, βIII-tubu-
lin (1:800, Sigma) for neurons, glial fibrillary acidic pro-
tein (GFAP, 1:200, Sigma) for astrocytes, or the
monoclonal mouse antibodies IgM against O4 (1:600, R
& D, Minneapolis, MN, USA) and the monoclonal mouse
antibodies IgG against myelin basic protein (MBP, 1:40,
Siemens Inc, Oncogene Group, Cambridge, MA, USA) for
oligodendrocytes. After being washed with PBS, sections
and cell cultures were incubated for 60 min at 37°C with
the appropriate secondary antibody: fluorescein isothio-
cyanate (FITC)-conjugated goat anti-mouse IgM (1:100,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), FITC-
conjugated goat anti-mouse IgG (1:100, Sigma), rhodam-
ine-conjugated goat anti-mouse IgM (1:200, Santa Cruz
Biotechnology), and rhodamine-conjugated goat anti-
mouse IgG (1:100, Sigma). After staining, the slides or
coverslips were rinsed and mounted with Gel/Mount
aqueous mounting media (Biomeda Corp., Foster City,
CA, USA) containing Hoechst 33342 (1 μg/ml, Sigma), a
fluorescent nuclear dye. The images were acquired using
an Olympus BX60 microscope equipped with a digital
camera and SPOT 4.0.1(G) software. For cell counts, at
least five randomly selected fields with a total of more
than 1000 cells were counted. For neurite outgrowth
assay, the neurite lengths of a total of 50 neurons in each
group from four independent experiments were measured
with a Neurolucida system (MicroBrightField Inc., Col-
chester VT, USA). In all experiments, primary antibody
omission controls were used to confirm the specificity of
Immunocytochemistry.
Western blot analysis
Dissociated NPCs were seeded into 60-mm dishes (Corn-
ing Inc.) and cultured in D/F12 medium containing 1%
FBS for 5 days, with or without Chase ABC administra-
tion. Then cells were washed and lysed with a lysis buffer
(50 mM Tris-HCl, 150 mM NaCl buffer, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM
sodium orthovanadate, 10 mM sodium fluoride, 4 μg/ml
leupeptin, 1 μg/ml aprotinin and 100 μg/ml PMSF; all
from Sigma). The supernatant was clarified by centrifuga-
tion at 16,000 g for 10 min at 4°C. The protein concentra-
tion of the lysate was determined using a BCA Protein
Assay kit (Pierce, Rockford, IL, USA). For western blotting,
Protein samples containing an equal amount of protein
(15  μg) were electrophoresed on SDS-polyacrylamide
gels, and transferred to polyvinylidene difluoride filters
(Millipore, Bedford, MA, USA). The filters were blocked
with 5% non-fat dry milk in Tris-buffered saline (TBS) for
1 hour at RT and then incubated overnight at 4°C with
primary antibodies (in TBST-5% BSA) including GFAP
(1:1000, Sigma), βIII-tubulin (1:2000, Sigma), MBP
(1:100, Oncogene) as markers for the differentiated neu-
ral cells, and GAPDH (1:8000, Kangchen Bio-Tech) as an
internal control. After being rinsed with TBST, the mem-
branes were incubated with the secondary antibody HRP-
conjugated goat anti-mouse IgG (1:1000, R & D) for 1
hour at RT. To visualize the immunoreactive proteins, the
ECL kit (Pierce) was used, following the manufacture's
instructions.
FACS analysis
For flow cytometric analysis of DNA content, NPCs were
cultured in medium alone or incubated with Chase ABC
at 37°C for 48 hours, and approximately 106 cells were
harvested, washed with ice-cold PBS, then fixed with 70%
ethanol at 4°C overnight. After that, fixed cells were
washed in PBS and re-suspended in a staining solutionBMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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containing 50 μg/mL propidium iodide (BD Pharmingen)
in 0.1% sodium citrate, 0.1% NP-40, and 12.5 μL ribonu-
clease (RNase) 1 mg/mL. Cells were incubated for 15 min
at 37°C, then kept in the dark and analyzed using a FAC-
SCalibur (BD Biosciences, Mountain View, CA, USA) with
excitation at 480 nm and the fluorescent signal was col-
lected at 585 nm. Cell cycle populations in the G1-, S-,
and G2-phases were quantified with the ModFit LT v3.0
software.
Cell migration assay
Neurospheres of passage 2, grown for 3 days in growth
medium supplemented with EGF and bFGF, were uni-
formly seeded on the well bottoms of a sterile 35-mm
dish, which were in advance coated with Laminin (10 μg/
mL, Invitrogen). Neurospheres were plated at low density
to ensure large distance between individual spheres and
incubated with Chase ABC at 37°C in NPCs growth
medium containing EGF and bFGF. The control groups
were grown under identical conditions except for Chase
ABC. At three selected time point, i.e. 2, 4.5 and 8 hours,
the cultures were observed and photographed by an
inverted microscope (IX70, Olympus, Tokyo, Japan)
equipped with a CCD camera (DP70, Olympus). Three
samples were evaluated for each set of conditions, and a
total of more than 30 neurospheres at each selected time
point were randomly captured and imaged. The average
migration distance of the neurospheres was expressed by
the diameter of the spheres surrounded by the rim of
migrating cells, based on previous reports [7,15], and rep-
resented as the mean of the straight-line measurement
from the center of the neurosphere to the farthest defined
edge of the migratory cell boundary in four vertical direc-
tions using SPOT 4.0.1(G) software.
Integrin blocking test
For neurosphere growth test, NPCs were divided into 4
groups: control group in regular growth medium, Chase
ABC treatment group, integrin blocking group which were
incubated with Echistatin (Ech, Sigma), the most potent
known inhibitor of integrin function, and combined
group with Chase ABC and Ech. The NPCs cultured on the
uncoated dishes in the growth medium containing EGF
and bFGF, were observed and photographed 24 hours
after culture, by an inverted microscope (IX70, Olympus)
equipped with a CCD camera (DP70, Olympus). For dif-
ferentiation experiments, there were 3 groups: control
group, Chase ABC group, and Chase ABC+Ech group. The
dissociated NPCs of each group were cultured on the poly-
L-lysine coated coverslips in differentiation medium with
1% FCS for 5 days, then, fixed with 4% PFA for MBP
immunostaining as described above.
Statistical analysis
Data were presented as mean ± standard error of the mean
(SEM) values. Statistical analysis was performed by SPSS
10.0 and One-way analysis of variance (ANOVA) with
post hoc Tukey LSD test or two-tailed independent sample
T-Test was used to determine statistical significance. A P-
value less than 0.05 was considered statistically signifi-
cant.
Results
Expression of CSPGs on NPCs in vitro
When dissociated NPCs from E16 rat embryonic fore-
brains were cultured in serum-free N2/B27 growth
medium supplemented with EGF and bFGF, they prolifer-
ated rapidly to form floating neurospheres. The immu-
nostaining of sectioned neurospheres indicated that
nearly all cells within spheres expressed the intermediate
filament protein (Nestin), a marker for NPCs (Fig. 1A).
After removal of EGF and bFGF and addition of 1% FBS,
the NPCs plated on the poly-L-lysine coated coverslips
began to differentiate along three neural lineages into a
mixture of βIII-tubulin+ neurons, GFAP+ astrocytes and
O4+ or MBP+ oligodendrocytes.
Subsequently, the expression patterns of CSPGs on NPCs
and their lineage cells, including neurons, astrocytes, and
oligodendrocytes were tested by double immunofluores-
cence staining with anti-CS56 antibody (special to Chon-
droitin sulfate moiety of CSPGs) and anti-Nestin, GFAP,
βIII-tubulin and MBP antibodies respectively. The results
showed that CSPGs were constitutively expressed on Nes-
tin+ NPCs (Fig. 1A-C) and also expressed on differentiated
GFAP+ astrocytes (Fig. 1G), βIII-tubulin+ neurons (Fig.
1H) and MBP+ oligodendrocytes (Fig. 1I). Moreover, the
expression of CSPGs could also be observed on the disso-
ciated NPCs cultured on the coverslips in the growth
medium containing EGF and bFGF (Fig. 1J, K), but dimin-
ished after Chase ABC (50 mU/mL) treatment for 48
hours (Fig. 1L, M). As anti-CS56 antibody directed against
the Chondroitin sulfate glycosaminoglycan (CS-GAG)
chains of CSPGs, this result indicated that Chase ABC
treatment could result in complete removal of the CS-
GAG chains from the surface of NPCs.
Effects of Chase ABC on the morphology of NPCs 
expanded in spheres
To explore the possible roles of endogenous CSPGs in the
growth and differentiation of NPCs, we examined the
effects of CSPGs on the morphology, proliferation, migra-
tion and differentiation of cultured NPCs by treating them
with Chase ABC which abolished the function of endog-
enous CSPGs by the removal of CS-GAG side chains
bounded on their core proteins.
First, we examined the effect of Chase ABC on the mor-
phology of NPCs expanded in spheres. When dissociated
NPCs were cultured in serum-free N2/B27 growth
medium supplemented with EGF and bFGF, they prolifer-
ated rapidly to form floating neurospheres 24 hours laterBMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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(Fig. 2A). However, the NPCs in the completely identical
growth medium, tended to turn flat and attach to the
untreated bottom of the culture wells after Chase ABC (10
mU/mL) treatment for 24 hours, and only a few of them
could still form small floating neurospheres, though the
NPCs under treatment of Chase ABC could still proliferate
rapidly during the initial culture. (Fig. 2B). Meanwhile,
some NPCs migrated out of the spheres, the globular cells
began to elongate, and irregular and small processes
emerged from the cell bodies (Fig. 2C). As time went on,
this tendency was more obvious. Most of neurospheres
were adherent to the bottom of the well and spread out-
ward to form irregular cell clusters which were surrounded
by a layer of reticular, spindle-like cells in the periphery
(Fig. 2D). In addition, the effects on the morphological
change of neurospheres could occur in a wide concentra-
tion range of Chase ABC, from 0.5 to 50 mU/mL, even at
a concentration of 0.1 mU/mL, although after administra-
tion of 50 mU/mL of Chase ABC, the NPCs attached to the
bottom of well more quickly than that treated with lower
doses of Chase ABC. It indicates that CSPGs, either
expressed on the surface of NPCs or secreted into the
ECM, may play an important role in maintaining the
shape of NPCs and further, the fate of neurospheres.
Effects of Chase ABC on the proliferation of NPCs
Second, we studied whether Chase ABC treatment would
influence the proliferation of NPCs by [3H] thymidine
incorporation. The disassociated NPCs were cultured in
the NPC growth medium containing EGF and bFGF and
examined after 24 hours exposure to different concentra-
tion of Chase ABC or without. The results showed that
administration of Chase ABC at a dose of 0.05 to 5 mU/
mL resulted in a significant increase in [3H] thymidine
CSPG Expression on NPCs in vitro Figure 1
CSPG Expression on NPCs in vitro. (A-C) Immunofluo-
rescence double staining of Nestin (A, red) and CSPGs (B, 
green) on neurospheres showed that almost all NPCs 
expressed CSPG (C, merge). The NPCs from E16 rat embry-
onic forebrains were cultured for 3 days in the NPC growth 
medium supplemented with EGF and bFGF. (D-F) The nega-
tive controls consisted of omission of the primary antibody. 
(G-I) The differentiated NPCs were double immunostained 
using anti-CS56 antibody (green) and anti-GFAP, βIII-tubulin 
and MBP antibodies (red) respectively. The result showed 
that CSPGs were expressed on GFAP+ astrocytes (G), βIII-
tubulin+ neurons (H) and MBP+ oligodendrocytes (I). (J-M) 
The expression of CSPGs was observed on the dissociated 
NPCs culture in the growth medium containing EGF and 
bFGF (J, K), but diminished after Chase ABC (50 mU/mL) 
treatment for 48 hours (L, M). Hoechst 33342 (blue) was 
used to stain the nuclei. Scale bars: A~F, 100 μm; G~M, 50 
μm.
Chase ABC induced morphological changes of NPC spheres Figure 2
Chase ABC induced morphological changes of NPC 
spheres. (A) A phase-contrast photomicrograph shows 
floating neurospheres derived from disassociated NPCs cul-
tured for 24 hours in growth medium supplemented with 
EGF and bFGF;. (B-D) Exposure of neurospheres to Chase 
ABC for 24 hours (B, C) and 48 hours (D) induced the neu-
rospheres to attach to the bottom of the wells and migration 
of cells outward to form irregular cell clusters. Boxed area in 
(B) is viewed in (C) at higher magnification, which showed 
that many NPCs migrated out of the spheres and emerged 
irregular small processes from the cell body. Scale bar: A and 
C, 100 μm; B and D, 200 μm.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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incorporation, about 19-20% higher than the control (P <
0.05). Treatment of higher dose of Chase ABC, i.e. 50 mU/
mL, did not bring more striking effects and showed no sig-
nificant difference compared to the control (P > 0.05)
(Fig. 3A).
To further elucidate the influence of Chase ABC on the
proliferation of NPCs, we subsequently examined
changes in cell cycle after Chase ABC treatment by flow
cytometric analysis of the DNA content (propidium
iodide staining). We used 5 mU/mL of Chase ABC as treat-
ment group which had shown higher proliferation in the
[3H] thymidine incorporation test. However, after treat-
ment for 48 hours, significant changes did not occur in
cell populations at the G1- and S-phases whereas the cells
in G2-phase decreased significantly (8.93 ± 1.58%) com-
pared to the control (11.48 ± 1.30%, P < 0.05) (Fig. 3B-
C). We also observed changes in cell cycle 24 hours after
the Chase ABC treatment, which were similar to that
observed in the cell population analysis (data not shown).
Therefore, interfering with the function of endogenous
CSPGs with Chase ABC did not affect the cell cycle of
NPCs except the cells in G2-phase.
Chase ABC treatment enhanced the migration of NPCs 
out of spheres
To investigate whether Chase ABC treatment would affect
the migration of NPCs, we then assessed NPCs motility by
using a previously described bulk neurosphere assay
[7,15]. The neurospheres, cultured in growth medium for
3 days, were uniformly seeded into wells coated with Lam-
inin and treated with or without Chase ABC (50 mU/mL).
The neurospheres attached to the well bottom within 1
hour and individual NPCs migrated rapidly away from
the spheres, resulting in a rim of cells that formed a mon-
olayer around the spheres, especially apparent on the
periphery of the attached neurospheres. We selected 3
time points, i.e. 2, 4.5 and 8-hour to examine the spheres'
motility (Fig. 4A), because after that, most of the cells
from the spheres migrated outward too far to be com-
pletely recorded in a field of view of a microscope.
The average migration distance of the NPCs in spheres
was expressed by the diameter of the spheres including the
rim of migrating cells. The average diameters at the three
selected time points were 320.0 ± 45.1 μm, 501.9 ± 83.4
μm and 660.0 ± 93.0 μm respectively in Chase ABC
treated wells compared to 287.4 ± 47.8 μm, 444.9 ± 76.4
μm and 579.6 ± 89.7 μm, respectively, in controls. Chase
ABC treatment promoted greater migration of NPCs than
that of the control at all selected time points (P < 0.01 at
2-hour and 8-hour; P < 0.05 at 4.5-hour) (Fig. 4B). This
indicates that interfering with the function of CSPGs on
NPCs enhances the migration of NPCs out of spheres. It
also indicates that CSPGs is inhibitory to the migration of
NPCs and may contribute to the formation of NPC
spheres.
Effects of Chase ABC on the differentiation of NPCs in 
vitro
To investigate whether Chase ABC treatment would affect
the fate of NPCs, We next examined the differentiation of
NPCs plated on poly-L-lysine-coated coverslips in differ-
entiation medium. The results showed that the treatment
of Chase ABC (50 mU/ml) on NPCs for 5 days in the pres-
ence of 1% FBS resulted in a significant increase of β-III
tubulin+ neurons (34.5% ± 9.9% vs 26.2% ± 6.6%, P <
0.05, Fig. 5A-B, I), and a decrease of GFAP+ astrocytes
(39.8% ± 7.9% vs 55.4% ± 6.4%; P < 0.01, Fig. 5C-D, I)
compared to the control. Further more, we found that the
morphology of GFAP+ astrocytes generated from NPCs
under Chase ABC treatment was a little different from
those in the control, most of which exhibited type-II astro-
cytes morphology with stellate cell body, but owning
longer and more highly branched processes than those
seen in the control (Fig. 5D). Meanwhile, we also found
that O4+ oligodendrocytes exhibited more mature mor-
phology in Chase ABC treated group than the control,
although the percentage of O4+ oligodendrocytes showed
no statistical difference between the treated and control
groups (7.03% ± 1.90% vs 8.02% ± 1.76%, P > 0.05, Fig.
5E, F, I). The typically mature morphology of oli-
godendrocyte from treated group was shown in Fig. 5F.
When a more mature marker MBP was used, Chase ABC
treatment significantly increased the percentage of highly
branched MBP+ mature oligodendrocytes (4.28% ± 0.66%
vs 1.08% ± 0.63%, P < 0.01, Fig. 5G-I).
To further confirm the immunostaining results, we exam-
ined the expression of differentiation marker proteins (β-
III tubulin, GFAP and MBP) with Western blot analysis. As
shown in Fig. 5J, both β-III tubulin and MBP were mark-
edly up-regulated after Chase ABC treatment, consistent
with the immunostaining results. However, the expres-
sion of GFAP in the treated group was not decreased as
shown in the GFAP immunostaining. As the astrocytes dif-
ferentiated from NSCs in Chase ABC treated group own-
ing longer and more highly branched processes, we
speculated that they might express more GFAP than those
in the control. Taken together, these results suggest that
CSPGs, whether expressed on the surface of NPCs or
secreted into extracelluar matrix, may play an important
role in controlling the differentiation of NPCs by some
unknown direct or indirect mechanisms. Abolishing the
function of CSPGs therefore may change the differentia-
tion pattern of NPCs.
As Chase ABC treatment could significantly increase neu-
ronal differentiation from NPCs, we further compared the
neurites outgrowth in neurons differentiated from NPCsBMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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Effects of Chase ABC treatment on the proliferation of NPCs in vitro Figure 3
Effects of Chase ABC treatment on the proliferation of NPCs in vitro. The dissociated NPCs were cultured in 
growth medium containing EGF and bFGF for 24 or 48 hours with or without Chase ABC. (A) Bar graph shows that Chase 
ABC treatment for 24 hours enhanced NPC proliferation at a dose of 0.05 to 5 mU/mL, measured as percentage of control 
radioactive counts (cpm value). Data represent mean ± SEM of three independent experiments performed in triplicate. * P < 
0.05. (B-C) Cell cycle was analysed by FACS, 48 hours after Chase ABC treatment on NPCs. (B) Histograms indicate the DNA 
distribution in control and Chase ABC treated groups. (C) The percentages of cell populations in G1-, G2-, and S-phases were 
derived from DNA histograms (B) by a deconvolution analysis. The results showed that the treatment of Chase ABC barely 
affected the cell cycle except for the G2-phase. Data shown were mean ± SEM of four independent experiments. * P < 0.05.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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using β-III tubulin immunostaining at early stages of neu-
ronal differentiation (green, Fig. 6A). Neurite outgrowth
was analyzed by measuring the total, average and longest
neurite length per cell, the number of primary neurites
extending from the cell body, and the order number of
branch points per cell. The results showed that neurons in
Chase ABC treated group had greater total neurite length
(143.9 ± 72.5 μm vs 102.7 ± 50.7 μm, P < 0.01), more pri-
mary neurites (2.04 ± 0.75 vs 1.63 ± 0.67, P < 0.01) and
higher order number of branch points (1.46 ± 0.61 vs 1.08
± 0.28, P < 0.01) than those in the control (Fig. 6B, C). The
average neurite length and the length of the longest neur-
ite of each neuron in the treated group were slightly longer
than that of the control but the difference was not statisti-
cally significant (70.1 ± 28.9 μm vs 67.2 ± 25.7 μm; 81.8
± 35.7 μm vs 77.8 ± 31.1 μm, respectively, both P > 0.05;
Fig. 6B). These results suggest that digesting the CSPGs on
NPCs or in ECM not only increases the neuronal differen-
tiation from NPCs but also enhance neurite outgrowth
from these neurons.
Integrins mediated the changes in the growth and 
differentiation of NPCs after exposure to Chase ABC
It was suggested that CSPGs in the CNS might function by
directly or indirectly binding the integrins on the surface
of neural cells [30], moreover, NPCs was reported to
express several integrins on their surface [10]. To gain
insight into the regulation mechanism of CSPGs on the
biological properties of NPCs and determine whether
integrin signal pathways are involved in the regulatory
function of CSPGs on NPCs, we examined the influence
of Chase ABC on NPCs properties in the presence or
absence of Echistatin (Ech), the most potent known
inhibitor of integrin. We first studied the morphological
changes of the NPCs under the treatment of Chase ABC
and Ech (Fig. 7). We found that Ech (0.2 μM) alone did
not induce obvious changes in the morphology of neuro-
spheres at 24 hours post-administration. The dissociated
NPCs still grew and formed floating neurospheres, though
a little small and the cell vitality was a little poor (Fig. 7B).
As anticipated, Chase ABC (10 mU/mL) treatment signif-
Migration of NPCs out of neurospheres was enhanced by treatment of Chase ABC Figure 4
Migration of NPCs out of neurospheres was enhanced by treatment of Chase ABC. (A) Neurospheres were 
imaged at 2, 4.5 and 8 hours after plating into the culture wells with or without Chase ABC. (B) The quantification of NPC 
migration at 2, 4.5 and 8 hours were performed by measuring the diameters of the spheres surrounded by rim of migrating 
cells, and the results were showed in a time course graph. Data represent the mean ± SEM obtained from three independent 
experiments with a total of more than 30 neurospheres examined in each time point. * P < 0.05, ** P < 0.01. Scale bars: 200 
μm.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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Effects of Chase ABC on the differentiation of NPCs in vitro Figure 5
Effects of Chase ABC on the differentiation of NPCs in vitro. (A-D) Treatment of Chase ABC on NPCs for 5 days 
resulted in a substantial increase in the number of β-III tubulin+ neurons (green, B) and decrease in the number of GFAP+ astro-
cytes (green, D) as compared to the control (A and C, respectively). (E, F) No significant difference was found in the number of 
O4+ (red) between the two groups. However, in the Chase ABC treated group, the O4+ oligodendrocytes showed more 
mature morphology (F). (G, H) Chase ABC treatment brought about more mature MBP+ oligodendrocytes (green, H) as com-
pared to the control in differentiated NPCs. Hoechst 33342 was used as a nuclear marker for the estimation of cell numbers 
(A-H). Scale bar: 50 μm. (I) Quantitative data demonstrate that treatment of NPCs with Chase ABC resulted in a significant 
increase in the number of β-III tubulin+ neurons (P < 0.05), decrease of GFAP+ astrocytes (P < 0.01), no change of O4+ oli-
godendrocytes (P > 0.05) and increase of MBP+ oligodendrocytes (P < 0.01). Data were shown as mean ± SEM of three inde-
pendent experiments with a total of more than 1000 cells examined in each group. * P < 0.05, ** P < 0.01. (J) Western blot 
analysis shows that Chase ABC treatment resulted in a marked increase in the expression of β-III tubulin and MBP in differen-
tiated NPCs, which were consistent with the immunostaining results. However, the expression of GFAP in the Chase ABC-
treated group showed no obvious change.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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icantly increased the percentage of attached neurospheres
compared to the control (72.02% ± 10.89% vs 1.20% ±
2.16%, P < 0.01; Fig. 7C, E). But when both Chase ABC
and Ech were administered, Ech could significantly
reverse the effect of Chase ABC on the morphology of neu-
rospheres, the percentage of attached neurospheres was
decreased to 9.86% ± 4.53% (P < 0.01, Fig. 7D, E).
A previous report revealed that the signal from integrins
could regulate the morphological differentiation of oli-
godendrocytes [31]. As our result showed that Chase ABC
treatment induced NPCs to differentiate into more MBP+
mature oligodendrocytes, we asked whether the integrin
inhibitor Ech could arrest the effect of Chase ABC on the
differentiation of NPCs into mature oligodendrocytes. As
anticipated, Chase ABC (10 mU/mL) treatment signifi-
cantly increased the percentage of MBP+ oligodendrocytes
(4.09% ± 0.65% vs 1.10% ± 0.62%, P < 0.01; Fig. 8D)
with more mature morphology (boxed area of Fig. 8B)
compared to the control. While in Chase ABC and Ech
(0.2 μM) treated groups (Fig. 8C), the percentage of MBP+
oligodendrocytes was decreased to 1.45% ± 0.37% (P <
0.01) compared with Chase ABC treated group and
returned to the control level (P > 0.05; Fig. 8D).
Thus, our results provide evidence that Ech can reverse the
effects of Chase ABC on the morphology of NPCs and
maturation of their progeny oligodendrocytes. As Ech is
the most potent inhibitor of integrins, it suggests that
CSPGs might be a native inhibitor of integrins. It also sug-
Effects of Chase ABC treatment on neurite outgrowth of neurons derived from NPCs Figure 6
Effects of Chase ABC treatment on neurite outgrowth of neurons derived from NPCs. (A) NPCs were differenti-
ated in 1% FCS for 5 days in the presence or absence of Chase ABC to allow differentiation into neurons with concomitant 
extension of neurites recognized by β-III tubulin immunostaining. Nuclei were counterstained with Hoechst 33342. Scale bar: 
50 μm. (B) Total, average and the longest neurite lengths of each NPC-derived neuron were determined by Neurolucida soft-
ware. The total neurite length per cell in Chase ABC treated group was longer than that in control, but no differences were 
found in average neurite length and the longest neurite length between the two groups. (C) The NPC-derived neurons in 
Chase ABC treated group showed more elaborate networks of neurites, including the number of primary neurite and the 
branch order, than the control. Data in B and C were measured with Neurolucida system and expressed as the mean ± SEM of 
four separate experiments with a total of 50 neurons examined in each group. **P < 0.01, treated vs control.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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gests that the integrin signal pathway may be involved in
the regulation of CSPGs on the growth and differentiation
of NPCs.
Discussion
The role of CSPGs on the biological properties of NPCs
The extracellular matrix (ECM) in the CNS plays a crucial
role in neural development and neuropathology for its
involvement in multiple developmentally- related proc-
esses including cell migration, neurite extension, synap-
togenesis and synaptic plasticity. It has been well known
that CSPGs are major components of the ECM in the CNS
and major barriers to neural regeneration after traumatic
injury in the adult CNS. However, like the other regenera-
tion-inhibitory molecules, CSPGs are normal constitutive
elements of the CNS and play physiological roles in the
intact nervous tissue. Several lines of evidence indicate
that CSPGs participate in different ontogenetic processes
including neurogenesis and gliogenesis, cell migration,
axon growth, and pathfinding [18,19]. In addition, the
formation of CSPGs pericellular nets is associated with
stabilization of synaptic contact and closure of critical
periods [20].
Our present study demonstrated that CSPGs were also
constitutively expressed on NPCs, which was consistent
with a previous study identifying two isoforms of CSPGs
phosphacan and RPTPβ on the surface of NPCs [32].
Another study also reported the presence of CSPGs in the
NPC niches during late development and in the adult
CNS [33]. Despite their morphological localization, little
has been known about the function of these cell surface-
associated molecules. In the present study, we used Chase
ABC to degrade the CSPGs and determined the role of
CSPGs on biological properties of NPCs. Our results dem-
onstrate that digestion of CSPGs enzymatically resulted in
substantial changes in morphology, migration and differ-
entiation of NPCs. A striking morphological change was
the significant reduction of their capacity to form neuro-
Effects of Chase ABC on NPC morphology blocked by  Echistatin (Ech) Figure 7
Effects of Chase ABC on NPC morphology blocked 
by Echistatin (Ech). (A) A phase-contrast photomicro-
graph shows that floating neurospheres were formed from 
dissociated NPCs when cultured for 24 hours in the growth 
medium containing EGF and bFGF. (B) Application of Ech 
alone did not affect the morphology of neurospheres. (C) 
Exposure to Chase ABC induced neurospheres to attach to 
the bottom of the well and migration of cells outward. (D) 
Ech administration blocked the effects of Chase ABC in that 
NPCs maintained their inherit growth properties. Scale bar: 
200 μm. (E) Quantitative data demonstrated that Chase ABC 
treatment resulted in a significant increase in the percentage 
of attached neurospheres, which could be blocked by the 
administration of Ech. Data were shown as mean ± SEM of 
four independent experiments with at least 350 neuro-
spheres examined in each group. ** P < 0.01.
Ech blocked the effect of Chase ABC on the differentiation of  NPCs into oligodendrocytes Figure 8
Ech blocked the effect of Chase ABC on the differen-
tiation of NPCs into oligodendrocytes. (A-C) Repre-
sentative immunofluorescence photomicrographs of 
oligodendrocytes (MBP+, green) differentiated from NPCs in 
the control (A), Chase ABC treated (B), and Chase ABC + 
Ech treated (C) groups. Hoechst 33342 (blue) was used to 
stain the nuclei. Scale bar: 50 μm. Boxed area in B showed 
mature morphology of an oligodendrocyte. (D) Quantitative 
data demonstrate that the Chase ABC treatment on NPCs 
resulted in a significant increase in the number of MBP+ oli-
godendrocytes. Such an effect of Chase ABC could be mark-
edly blocked by the administration of Ech. Data were shown 
as mean ± SEM of four independent experiments. ** P < 0.01.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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spheres after Chase ABC treatment, consistent with the
reports from Von HA and Sirko S [32,34]. But on the pro-
liferation and differentiation of NPCs after Chase ABC
treatment, our results were not completely identical with
theirs [34], which might be due to different cell origin and
detection methods. Kabos et al. reported that the expres-
sion of CSPGs on the NPCs was down-regulated with dif-
ferentiation [35]. Though we did not detect the expression
of CSPGs on NPCs and their lineage cells by Western blot-
ting, and could not compare the expression of CSPGs
among them, in this study, with double immunostaining,
we found that CSPGs were also expressed on differenti-
ated NPCs, which were consistent with our previous
report [36]. Of course, the expression patterns of different
kinds of CSPGs during NPCs differentiation remain to be
explored.
As for the effect of Chase ABC treatment on the prolifera-
tion of NPCs, an important statement should be men-
tioned. Cell growth can occur via two different
mechanisms: speeding up the rate of DNA synthesis in
cells that have entered the S-phase; or raising the number
of cells that have entered S-phase. The two assays ([3H]
thymidine incorporation and cell cycle analysis) that we
used could detect the two situations respectively and fully
reflect the effects of Chase ABC on the proliferation of
NPCs. Our results indicated that Chase ABC treatment did
not change the cell cycle except the cells in G2-phase.
However, as it affected the three dimensional structures of
neurospheres, the NPCs in Chase ABC treated groups, due
to moving out of the spheres, could uptake thymidine
more easily and therefore enhance the growth of NPCs as
shown in the results of [3H] thymidine incorporation. But
we found that the treatment of 50 mU/ml Chase ABC did
not significantly affect thymidine incorporation. In order
to confirm the results from [3H] thymidine incorporation
test, we also performed MTT test, a conventional method
to evaluate the proliferation of cells cultured in vitro. The
results of MTT assay showed that administration of Chase
ABC at a dose of 0.5 and 5 mU/mL resulted in a significant
increase in the proliferation of NPCs (P < 0.05), but at a
dose of 0.05 and 50 mU/mL, no significant differences
were observed (P > 0.05) (data not shown in detail). It
indicated that the results from MTT were consistent with
the outcome of [3H] thymidine incorporation test except
the result of 0.05 mU/mL Chase ABC treatment group. As
the samples treated with 0.05 or 50 mU/mL Chase ABC
had relatively large standard deviations, we supposed that
at lower and higher doses, it might be the actual experi-
ments too variable to allow significant differences to be
seen (Fig. 3A).
The other changes such as the migration and differentia-
tion of NPCs after Chase ABC treatment might be a result
of disaggregation of neurospheres. Although the exact
relationship between neurosphere-forming cells in vitro
and neural progenitor cells in vivo remains to be estab-
lished, the neurosphere assay remains to be the best cell
culture model for evaluating NPC biological properties.
With that regard, the current results concerning the role of
CSPGs on neurosphere forming in vitro should shed light
on the behavior of neural progenitor cells in vivo. The pre-
vious studies revealed that the function of CSPGs was
depended on their glycosaminoglycan (GAG) sulphated
sugar chains. CSPGs can associate directly with cell surface
adhesion molecules to enhance or block their function,
and the probable mechanism is that the protein core of
the CSPGs attaches to a matrix or cell surface molecule,
bringing the highly charged GAG chain into a position in
which it can mask or alter the structure of the target mol-
ecule, thereby affecting the downstream signal events and
evoking the according changes of specific behaviors [37].
We believe that CSPGs may, in this way, play an impor-
tant role in maintaining the morphology of NPCs in vivo
and thereby regulate the migration and differentiation of
NPCs during neural development.
Interactions between CSPGs and integrins in maintaining 
the biological character of NPCs
One family of cell adhesion molecules that has been
investigated in the context of brain development is the
integrins, the primary mediator of neural cell behavior on
ECM components. They are a major group of cell-surface
receptors for both ECM and cell-surface molecules. The
intergrins are composed of two non-covalently associated
transmembrane glycoproteins, α and β, both of which
participate in the binding of matrix proteins, and have
been implicated in activating intracellular biochemical
signaling pathways. For example, adhesion to ECM or
clustering of specific integrins receptors has been shown
to induce protein tyrosine phosphorylation, stimulate
inositol lipid metabolism, activate G proteins, and
enhance ion exchange across the cell surface [38,39]. ECM
binding and integrin engagement also result in transmis-
sion of mechanical stresses across the cell surface that pro-
duce changes in cytoskeletal organization and associated
alterations in cell shape [40-42]. In particular, the β1 fam-
ily of integrins controls various nervous system cell func-
tions, including survival [13], migration [14,15], neurite
outgrowth [16], and myelination [17]. They have also
been localized in various regions of the developing brain,
and are present on the surface of each of the major cell
types in the developing brain [15,43,44]. In addition,
integrin gene deletion and antibody perturbation studies
have demonstrated a functional role for integrin-ECM
interactions in proper brain formation [14,45,46]. But the
mechanisms by which such interactions contribute to fun-
damental NPC behaviors remain largely unexplored.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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Previous reports showed that neurospheres were enriched
in  β1 integrins [15] and the expression level of β1
integrins conditioned the number of secondary neuro-
spheres [12]. It is reasonable to speculate that the CSPGs
bound on the surface of NPCs, like that in the ECM,
through β1 integrins, modulate the behavior of NPCs by
cell-cell, cell-ECM interaction or crosstalk between mem-
brane receptors. To verify if integrins are involved in the
function of CSPGs, we used the Ech, an inhibitor of
integrins. Our results showed that Ech significantly
reversed some effects of Chase ABC on CSPGs i.e. mor-
phological change in neurospheres as well as maturation
of oligodendrocytes derived from NPCs, while blocking
integrins on NPCs alone did not significantly affect the
formation of new neurospheres. These results were con-
sistent with other reports in β1 integrin-deficient NPCs
[47].
Our study also showed that, after exposure to Chase ABC,
NPCs differentiated into more neurons, formed more
complex neurite network, and increased the migration of
neurospheres. Though we did not further explore the pos-
sible role of integrins beyond these phenomena, other
researchers have reported that migration of β1 integrin-
deficient neurospheres was significantly decreased on
laminin substrates, and their adhesion was also disturbed
[47]. These results suggest that the integrin signaling in
the NPCs may be involved in some biological changes
observed in the present study after the Chase ABC treat-
ment. We speculate that the integrin on the surface of
NPCs, by means of their ligands such as NCAM, Tenascin
or other binding molecules, indirectly interact with the
CSPGs bound on the cell surface or in the ECM and thus
construct a well-defined microenvironment by crosstalk
between membrane receptors or cell-ECM interaction,
which regulates the NPC behavior. We reason that CSPGs
may mask or alter the structure of integrins thereby inhib-
iting corresponding downstream signaling events making
NPCs at a stable status which may be beneficial to the
development of NPCs. Once we broke this balance by
degrading CSPGs with Chase ABC, the integrins may be
activated to induce a series of changes in the growth, adhe-
sion, migration and differentiation of NPCs. When Ech is
added, it inhibits integrins instead of CSPGs so that the
condition of NPCs is stabilized. These results suggest that
the integrin signal pathway might be involved in the reg-
ulation of CSPGs on some biological characters of NPCs
though a mechanism remains to be investigated.
Possible role of Chase ABC in mediating NPC-based cell 
transplantation
It has been well known that CSPGs are one of the inhibi-
tory molecules found in glial scars and inhibit neurite out-
growth and induce growth cone collapse after spinal cord
injury (SCI) [26,27] and Chase ABC application could
promote axonal regeneration by digesting CSPGs in vitro
[48] and in vivo [22,28,49,50]. In addition, NPC trans-
plantation is another promising strategy which promotes
axonal regeneration or neurite outgrowth by secreting
neurotrophic factors, remyelinating or reconnecting the
disrupted neuronal circuit [51-54]. Recently, researchers
attempted to combine Chase ABC application with NPC
transplantation to treat the injured spinal cord, and found
this combined treatment significantly induced the out-
growth of a greater number of growth-associated GAP-43-
positive fibers at the lesion epicenter, compared with NPC
transplantation alone [25]. They attributed the enhanced
effect to that Chase ABC attenuated the inhibitory effects
of CSPGs around the lesion cavity and facilitated NPCs
migration into host spinal cord. Results from our study
have added an additional explanation of these effects, i.e.
Chase ABC may have a direct effect on the growth and dif-
ferentiation of transplanted NPCs.
In our studies, we demonstrate that treatment of Chase
ABC did not inhibit the proliferation of NPCs nor their
inherent cell cycle in vitro, which may be a prerequisite for
the combination treatment of Chase ABC and NPC trans-
plantation. But Chase ABC treatment changed the mor-
phology of neurospheres and enhanced the migration of
NPCs in vitro. So it remains to be investigated whether
these changes would occur in vivo and benefit the migra-
tion of transplanted NPCs in the injured CNS.
An interesting observation is that Chase ABC induced
more neuronal differentiation and less astrocytic differen-
tiation from NPCs. If this also happens in vivo, then more
neurons may be generated from the NPCs after Chase ABC
application which may compensate for the loss of neu-
rons following the CNS injury and may benefit to recon-
nect the disrupted neuronal circuit. Meanwhile, more
mature oligodendrocytes differentiated from NPCs after
Chase ABC treatment may enwrap demyelinated or regen-
erated axons and therefore contribute functional recovery
after CNS injuries. Some investigators believe that pre-dif-
ferentiation of NPCs into neurons or oligodendrocytes in
vitro may be necessary to control the terminal lineage dif-
ferentiation of the transplanted cells [55]. Our results sug-
gest that combined application of Chase ABC and NPCs
may partly avoid this process in obtaining favorable cell
populations for repair. It should be noted that although
the percentage of GFAP+ astrocytes significantly decreased
after exposure to Chase ABC, many of them showed aber-
rant morphology similar to those seen after brain disor-
ders [56]. It is thus not clear whether these cells maintain
their normal function or behave abnormally such as those
seen after CNS injuries.BMC Neuroscience 2009, 10:128 http://www.biomedcentral.com/1471-2202/10/128
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Conclusion
Taken together, the present study investigating the influ-
ence and mechanisms of CSPGs on the differentiation
and migration of NPCs should help us to understand the
basic biology of NPCs during CNS development and pro-
vide new insights into developing new strategies for the
treatment of the neurological disorders in the CNS.
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